Delivery Order SPE2DB24D2100-SPE2DB25FBGNY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,791.52 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 31, 2025, and performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency (DLA) awarded a $3,430.71 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count units). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. Performance is scheduled for completion by September 3,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,136.83 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 mg patches (8-count) with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and represents a specific product delivery under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.93 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG patches (8-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for COMBIPATCH 0.05-0.14 mg patches in a quantity of 8 units. This is a firm fixed price delivery order with a ceiling value of $1,743.72 and an ultimate completion date of August 14, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for COMBIPATCH 0.05-0.14 MG transdermal patches (8-count packaging) with a ceiling value of $1,679.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for July 14, 2025, and performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- This federal contract award is for $1,466.98 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the medical product "COMBIPATCH 0.05-0.14 MG PTCH 8S" and has a completion date of December 23, 2024. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a $1,373.04 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical. This order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is not designated as a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,231.17 in Combipatch transdermal patches (0.05-0.14 mg), with an ultimate completion date of August 15, 2025. This competitive award, issued on August 14, 2025, carries a firm fixed price structure and involves no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.87, is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a medical product. The contract is a Firm Fixed Price delivery order with an ultimate completion date of October 21, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGNYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,343.76 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count unit). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract has an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime contract vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical vendor, particularly for Defense Health Agency and military healthcare systems. The company's comprehensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. All of the company's reviewed contract awards have been competitively awarded with firm fixed pricing, reflecting its established position within the federal medical supply chain and its ability to compete effectively against other qualified contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/23/25 |